Article Versions Notes

Yamada Y, Fujii H, Watanabe D, Kato-Hayashi H, Ohata K, Kobayashi R, Ishihara T, Uemura S, Iwashita T, Shimizu M, et al. Severe Neutropenia is Associated with Better Clinical Outcomes in Patients with Advanced Pancreatic Cancer Who Receive Modified FOLFIRINOX Therapy. Cancers. 2018; 10(11):454. https://doi.org/10.3390/cancers10110454

Yamada, Yunami, Hironori Fujii, Daichi Watanabe, Hiroko Kato-Hayashi, Koichi Ohata, Ryo Kobayashi, Takuma Ishihara, Shinya Uemura, Takuji Iwashita, Masahito Shimizu, and et al. 2018. "Severe Neutropenia is Associated with Better Clinical Outcomes in Patients with Advanced Pancreatic Cancer Who Receive Modified FOLFIRINOX Therapy" Cancers 10, no. 11: 454. https://doi.org/10.3390/cancers10110454

Yamada, Y., Fujii, H., Watanabe, D., Kato-Hayashi, H., Ohata, K., Kobayashi, R., Ishihara, T., Uemura, S., Iwashita, T., Shimizu, M., & Suzuki, A. (2018). Severe Neutropenia is Associated with Better Clinical Outcomes in Patients with Advanced Pancreatic Cancer Who Receive Modified FOLFIRINOX Therapy. Cancers, 10(11), 454. https://doi.org/10.3390/cancers10110454